(2) There is growing evidence that selective activation of PPARγ may reveal novel therapeutic targets for future generations of drugs in the treatment of both T2DM and atherosclerosis, and PTMs of PPARγ have shown great potential in this regard. This evidence concerns the gene PPARG and atherosclerosis.